Skip to main content

Table 2 Exposure risks with significant associations comparing HCV antibody positive and negative men who have sex with men from Zurich, stratified by HIV diagnosis

From: Prevalence of hepatitis C in a Swiss sample of men who have sex with men: whom to screen for HCV infection?

Factor (exposure risk)

HCV pos.1

HCV neg.

Fisher’s2

OR3

95% CI4of OR

(Without substitution of missing values)

n

%

n

%

HIV 5 diagnosis

        

Total sample (n = 840)

Yes

4

21.1

15

78.9

0.000

72.70

14.95-353.56

No

3

0.4

818

99.6

Non-Swiss origin

        

Total sample (valid n = 769)

Yes

5

2.8

173

97.2

0.009

8.51

1.64-18.75

No

2

0.3

589

99.7

No known HIV infection (valid n = 752)

Yes

1

0.6

171

99.4

0.542

1.69

0.15-18.75

No

2

0.3

578

99.7

HIV diagnosed (valid n = 17)

Yes

4

66.7

2

33.3

0.006

n.a. 7

 

No

0

0.0

11

100.0

Tattooed

        

Total sample (valid n = 727)

Yes

5

3.4

140

96.6

0.004

10.36

1.99-53.94

No

2

0.3

580

99.7

No known HIV infection (valid n = 710)

Yes

2

1.4

137

98.6

0.100

8.32

0.75-92.43

No

1

0.2

570

99.8

HIV diagnosed (valid n = 17)

Yes

3

50.0

3

50.0

0.099

10.00

0.74-135.33

No

1

9.1

10

90.9

NIDU 6 of cocaine or amphetamines NIDU only

        

Total sample (valid n = 727)

Yes

4

4.0

95

96.5

0.012

8.77

1.93-39.81

No

3

0.5

625

99.5

No known HIV infection (valid n = 710)

Yes

0

0.0

91

100.0

0.621

n.a.

 

No

3

0.5

616

99.5

HIV diagnosed (valid n = 17)

Yes

4

50.0

4

50.0

0.053

n.a.

 

No

0

0.0

9

100.0

  1. 1HCV pos./neg.: positive/negative for antibodies against hepatitis C virus; 2Fisher’s exact test; 3OR: odds ratio; 4CI: confidence interval; 5HIV: human immunodeficiency virus; 6NIDU: non-injection drug use; 7 n.a.: not applicable (division by zero).